Mark Haden
Corporate Officer/Principal en CLEARMIND MEDICINE INC. .
Fortuna: 150 $ al 31/05/2024
Cargos activos de Mark Haden
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CLEARMIND MEDICINE INC. | Corporate Officer/Principal | 01/07/2021 | - |
Historial de carrera de Mark Haden
Antiguos cargos conocidos de Mark Haden.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Psygen Labs, Inc.
 Psygen Labs, Inc. Pharmaceuticals: GenericHealth Technology Psygen Labs, Inc. is a psychedelics manufacturer that provides non-exclusive access to psychedelic drug products for clinical research and therapeutic applications. The company is based in Calgary, Canada. With over 50 years of combined experience synthesizing psychedelics, the Canadian company is well positioned to be a lead supplier for the emerging commercial market. The CEO of the company is Danny Motyka. | Corporate Officer/Principal | 01/04/2021 | 01/03/2022 |
Formación de Mark Haden.
| University of British Columbia | Graduate Degree |
Estadísticas
Internacional
| Canadá | 4 |
Operativa
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CLEARMIND MEDICINE INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Psygen Labs, Inc.
Psygen Labs, Inc. Pharmaceuticals: GenericHealth Technology Psygen Labs, Inc. is a psychedelics manufacturer that provides non-exclusive access to psychedelic drug products for clinical research and therapeutic applications. The company is based in Calgary, Canada. With over 50 years of combined experience synthesizing psychedelics, the Canadian company is well positioned to be a lead supplier for the emerging commercial market. The CEO of the company is Danny Motyka. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Haden
- Experiencia
